Drug Shortage Report for NOVAMOXIN
| Report ID | 169966 |
| Drug Identification Number | 00452130 |
| Brand name | NOVAMOXIN |
| Common or Proper name | TEVA-AMOXICILLIN SUS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | AMOXICILLIN |
| Strength(s) | 250MG |
| Dosage form(s) | GRANULES FOR SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 100,150 |
| ATC code | J01CA |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-09-22 |
| Estimated end date | 2023-07-10 |
| Actual end date | 2023-07-04 |
| Shortage status | Resolved |
| Updated date | 2024-02-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v32 | 2024-02-14 | English | Compare |
| v31 | 2023-07-05 | English | Compare |
| v30 | 2023-07-04 | French | Compare |
| v29 | 2023-07-04 | English | Compare |
| v28 | 2023-06-09 | French | Compare |
| v27 | 2023-06-09 | English | Compare |
| v26 | 2023-06-09 | English | Compare |
| v25 | 2023-06-09 | French | Compare |
| v24 | 2023-06-09 | English | Compare |
| v23 | 2023-04-27 | French | Compare |
| v22 | 2023-04-27 | English | Compare |
| v21 | 2023-02-02 | French | Compare |
| v20 | 2023-02-02 | English | Compare |
| v19 | 2023-01-19 | French | Compare |
| v18 | 2023-01-19 | English | Compare |
| v17 | 2023-01-12 | French | Compare |
| v16 | 2023-01-12 | English | Compare |
| v15 | 2022-12-22 | English | Compare |
| v14 | 2022-12-01 | French | Compare |
| v13 | 2022-12-01 | English | Compare |